Association between genetic variation of complement C3 and the susceptibility to advanced age-related macular degeneration: a meta-analysis
- PMID: 30352574
- PMCID: PMC6199710
- DOI: 10.1186/s12886-018-0945-5
Association between genetic variation of complement C3 and the susceptibility to advanced age-related macular degeneration: a meta-analysis
Abstract
Background: The purpose of this study is to discuss whether genetic variants (rs2230199, rs1047286, rs2230205, and rs2250656) in the C3 gene account for a significant risk of advanced AMD.
Methods: We performed a meta-analysis using electronic databases to search relevant articles. A total of 40 case-control studies from 38 available articles (20,673 cases and 20,025 controls) were included in our study.
Results: In our meta-analysis, the pooled results showed that the carriage of G allele for rs2230199 and the T allele for rs1047286 had a tendency to the risk of advanced AMD (OR = 1.49, 95% CI = 1.39-1.59, P < 0.001; OR = 1.45, 95% CI = 1.37-1.54, P < 0.001). Moreover, in the subgroup analysis based on ethnicity, rs2230199 and rs1047286 polymorphisms were more likely to be a predictor of response for Caucasian region (OR = 1.48, 95% CI = 1.38-1.59, P < 0.001; OR = 1.45, 95% CI = 1.37-1.54, P < 0.001). Besides, pooled results suggested that the G allele of rs2230199 could confer susceptibility to advanced AMD in Middle East (OR = 1.62, 95% CI = 1.33-1.97, P < 0.001).
Conclusion: In our meta-analysis, C3 genetic polymorphisms unveiled a positive effect on the risk of advanced AMD, especially in Caucasians. Furthermore, numerous well-designed studies with large sample-size are required to validate this conclusion.
Keywords: Age-related macular degeneration; C3 gene; Meta-analysis; Polymorphism.
Conflict of interest statement
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures






Similar articles
-
Nonsynonymous single nucleotide polymorphisms in the complement component 3 gene are associated with risk of age-related macular degeneration: a meta-analysis.Gene. 2015 May 1;561(2):249-55. doi: 10.1016/j.gene.2015.02.039. Epub 2015 Feb 15. Gene. 2015. PMID: 25688879
-
Association between a functional genetic polymorphism (rs2230199) and age-related macular degeneration risk: a meta-analysis.Genet Mol Res. 2015 Oct 16;14(4):12567-76. doi: 10.4238/2015.October.16.24. Genet Mol Res. 2015. PMID: 26505407 Review.
-
Association Between Complement Factor C2/C3/CFB/CFH Polymorphisms and Age-Related Macular Degeneration: A Meta-Analysis.Genet Test Mol Biomarkers. 2018 Sep;22(9):526-540. doi: 10.1089/gtmb.2018.0110. Epub 2018 Sep 4. Genet Test Mol Biomarkers. 2018. PMID: 30179527
-
Association of polymorphisms in complement component 3 with age-related macular degeneration in an Iranian population.Ophthalmic Genet. 2017 Jan-Feb;38(1):61-66. doi: 10.3109/13816810.2015.1126612. Epub 2016 Mar 30. Ophthalmic Genet. 2017. PMID: 27029644
-
Meta-Analysis of the Pharmacogenetics of ARMS2 A69S Polymorphism and the Response to Advanced Age-Related Macular Degeneration.Ophthalmic Res. 2021;64(2):192-204. doi: 10.1159/000508738. Epub 2020 May 19. Ophthalmic Res. 2021. PMID: 32428913 Review.
Cited by
-
Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics.Int J Mol Sci. 2021 Nov 21;22(22):12537. doi: 10.3390/ijms222212537. Int J Mol Sci. 2021. PMID: 34830419 Free PMC article. Review.
-
Choroidal Neovascularization: Mechanisms of Endothelial Dysfunction.Front Pharmacol. 2019 Nov 29;10:1363. doi: 10.3389/fphar.2019.01363. eCollection 2019. Front Pharmacol. 2019. PMID: 31849644 Free PMC article. Review.
-
Molecular Genetic Mechanisms in Age-Related Macular Degeneration.Genes (Basel). 2022 Jul 12;13(7):1233. doi: 10.3390/genes13071233. Genes (Basel). 2022. PMID: 35886016 Free PMC article. Review.
-
The complement system in lipid-mediated pathologies.Front Immunol. 2024 Nov 20;15:1511886. doi: 10.3389/fimmu.2024.1511886. eCollection 2024. Front Immunol. 2024. PMID: 39635529 Free PMC article. Review.
-
Complement family member CFI polymorphisms and AMD susceptibility from a comprehensive analysis.Biosci Rep. 2020 Apr 30;40(4):BSR20200406. doi: 10.1042/BSR20200406. Biosci Rep. 2020. PMID: 32215612 Free PMC article.
References
-
- Scholl HP, Fleckenstein M, Fritsche LG, Schmitz-Valckenberg S, Gobel A, Adrion C, Herold C, Keilhauer CN, Mackensen F, Mossner A, et al. CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD. PLoS One. 2009;4(10):e7418. doi: 10.1371/journal.pone.0007418. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous